Preclinical Evaluation of IMGC936, a Next-Generation Maytansinoid-based Antibody-drug Conjugate Targeting ADAM9-expressing Tumors.
Saved in:
| Title: | Preclinical Evaluation of IMGC936, a Next-Generation Maytansinoid-based Antibody-drug Conjugate Targeting ADAM9-expressing Tumors. |
|---|---|
| Authors: | Scribner JA; MacroGenics, Inc., Brisbane, CA., Hicks SW; ImmunoGen, Inc., Waltham, MA., Sinkevicius KW; ImmunoGen, Inc., Waltham, MA., Yoder NC; ImmunoGen, Inc., Waltham, MA., Diedrich G; MacroGenics, Inc., Rockville, MD., Brown JG; MacroGenics, Inc., Rockville, MD., Lucas J; ImmunoGen, Inc., Waltham, MA., Fuller ME; ImmunoGen, Inc., Waltham, MA., Son T; MacroGenics, Inc., Brisbane, CA., Dastur A; ImmunoGen, Inc., Waltham, MA., Hooley J; MacroGenics, Inc., Brisbane, CA., Espelin C; ImmunoGen, Inc., Waltham, MA., Themeles M; ImmunoGen, Inc., Waltham, MA., Chen FZ; MacroGenics, Inc., Brisbane, CA., Li Y; MacroGenics, Inc., Brisbane, CA., Chiechi M; MacroGenics, Inc., Brisbane, CA., Lee J; ImmunoGen, Inc., Waltham, MA., Barat B; MacroGenics, Inc., Rockville, MD., Widjaja L; MacroGenics, Inc., Rockville, MD., Gorlatov S; MacroGenics, Inc., Rockville, MD., Tamura J; MacroGenics, Inc., Rockville, MD., Ciccarone V; MacroGenics, Inc., Rockville, MD., Ab O; ImmunoGen, Inc., Waltham, MA., McEachem KA; ImmunoGen, Inc., Waltham, MA., Koenig S; MacroGenics, Inc., Rockville, MD., Westin EH; MacroGenics, Inc., Rockville, MD., Moore PA; MacroGenics, Inc., Rockville, MD., Chittenden T; ImmunoGen, Inc., Waltham, MA., Gregory RJ; ImmunoGen, Inc., Waltham, MA., Bonvini E; MacroGenics, Inc., Rockville, MD., Loo D; MacroGenics, Inc., Brisbane, CA. |
| Source: | Molecular cancer therapeutics [Mol Cancer Ther] 2022 Jul 05; Vol. 21 (7), pp. 1047-1059. |
| Publication Type: | Journal Article; Clinical Trial, Phase II; Clinical Trial, Phase I |
| Journal Info: | Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
